There is a certain amount of healthy skepticism in the field of psychiatry in relation to the use of biologically based diagnostic tests for schizophrenia mainly due to the fact that the VeriPsych early tests did not include tests of diagnostic specificity (schizophrenia versus other psychiatric disorders).
Hence this subunit could be used as a suitable agent for antibody antigen based diagnostic test.
However, the antigen based diagnostic test has some disadvantages: low sensitivity for detecting early active CMV infection or disease that may occur before engraftment due to the lack of leukocytes during the period of aplasia (requirement of neutrophil counts >0.5 × 10cells/L) and low positive predictive value for the occurrence of CMV gastroenteritis [ 12, 13].
These findings may also have relevance for IFN-γ based diagnostic tests where the hope is that quantification of level of response may be helpful to distinguish latent infection from active disease.
The aims of this study were to implement a quantitative nucleic acid-based diagnostic test for paucibacillary tuberculosis, enabling the identification and quantification of viable Mycobacterium tuberculosis bacilli by quantitative Real-Time PCR (qRT-PCR).
WKR is board-certified in general toxicology, and he is currently investigating the efficacy of cobinamide for treatment of hydrogen-sulphide-induced neurotoxicity, the development and validation of a tissue-based diagnostic test for aflatoxin B1 in liver and urine, and the cyanotoxin-applied research, diagnostic test methods, and impact of microcystin LR on human health and animal health.
He is currently investigating the efficacy of cobinamide for treatment of hydrogensulphide-induced neurotoxicity, the development and validation of a tissue-based diagnostic test for aflatoxin B1 in liver and urine, and the cyanotoxin-applied research, diagnostic test methods, and impact of microcystin LR on human health and animal health.
However, the potential benefits of a sensitive and reliable serum-based diagnostic test for a range of diseases, including cancer are so great that many efforts are being made to solve these problems.
To evaluate the RNA isolated under the various conditions with a functional test, 23 genes used in a clinically validated, gene expression-based diagnostic test for obstructive coronary artery disease [ 4] were assayed by RT-qPCR.
It can be hypothesized that the metabolite profile and thus the urine-based diagnostic test for colonic adenomatous polyps are not detecting the adenoma themselves, but instead the associated changes in the colonic microbiome.
To improve the diagnostic accuracy of cytology, we explored the feasibility of developing a genomic-based diagnostic test for bladder cancer that would use quantitative RT-PCR for data acquisition.
